Isabel Rodriguez-Barraquer, Ph.D.
Affiliations: | 2012 | Epidemiology | Johns Hopkins University, Baltimore, MD |
Area:
Epidemiology, Biostatistics Biology, Virology BiologyGoogle:
"Isabel Rodriguez-Barraquer"Parents
Sign in to add mentorDerek A. T. Cummings | grad student | 2012 | Johns Hopkins | |
(The shifting epidemiology of dengue: Insight from serological surveys.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hamins-Puértolas M, Buddhari D, Salje H, et al. (2023) Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort study. Nature Microbiology |
Takahashi S, Peluso MJ, Hakim J, et al. (2023) SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency. American Journal of Epidemiology |
Tan ST, Kwan AT, Rodríguez-Barraquer I, et al. (2023) Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. Nature Medicine |
Tan ST, Kwan AT, Rodriguez-Barraquer I, et al. (2022) Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. Medrxiv : the Preprint Server For Health Sciences |
Routledge I, Takahashi S, Epstein A, et al. (2022) Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2. Nature Communications. 13: 2451 |
Hu Z, van der Ploeg K, Chakraborty S, et al. (2022) Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. Research Square |
Routledge I, Takahashi S, Epstein A, et al. (2021) Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2. Medrxiv : the Preprint Server For Health Sciences |
Takahashi S, Peluso MJ, Hakim J, et al. (2021) SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency. Medrxiv : the Preprint Server For Health Sciences |
Salje H, Alera MT, Chua MN, et al. (2021) Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection. Nature Medicine |
Huang AT, Garcia-Carreras B, Hitchings MDT, et al. (2020) A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nature Communications. 11: 4704 |